EFG Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-82,472
| Closed | -$1.33M | – | 187 |
|
|
2025
Q1 | $1.33M | Sell |
82,472
-346
| -0.4% | -$5.58K | 0.22% | 162 |
|
|
2024
Q4 | $1.93M | Buy |
82,818
+30,608
| +59% | +$713K | 0.26% | 157 |
|
|
2024
Q3 | $1.53M | Buy |
52,210
+15,429
| +42% | +$453K | 0.26% | 163 |
|
|
2024
Q2 | $869K | Buy |
36,781
+25,630
| +230% | +$605K | 0.15% | 186 |
|
|
2024
Q1 | $423K | Buy |
+11,151
| New | +$423K | 0.07% | 190 |
|